Month: November 2022

On December 31, 2002, Costantino, Luca; Ferrari, Anna Maria; Gamberini, Maria Cristina; Rastelli, Giulio published an article.Formula: C7H6ClNO2 The title of the article was Nitrophenyl Derivatives as Aldose Reductase Inhibitors. And the article contained the following:

Nitrophenyl derivatives were recently discovered as a new class of ALR2 inhibitors by means of docking and database screening of the National Cancer Institute database of organic mols. The nitro group was predicted to bind to the Tyr48 and His110 active site residues of the enzyme, the site where acidic ALR2 inhibitors such as carboxylic acids bind in their anionic form. Given the novelty of these compounds, we decided to expand their structure-activity relationships by synthesizing and testing a series of derivatives and the corresponding compounds having a carboxylic group instead of the nitro moiety; the results obtained were rationalized by means of docking and mol. dynamics simulations. On the whole there is an agreement between inhibitory data and the results of mol. modeling experiments, supporting the hypothesized binding mode of these compounds The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Formula: C7H6ClNO2

The Article related to aldose reductase inhibitor nitrophenyl derivative preparation, Pharmacology: Structure-Activity and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On May 15, 2015, Maxson, Tucker; Deane, Caitlin D.; Molloy, Evelyn M.; Cox, Courtney L.; Markley, Andrew L.; Lee, Shaun W.; Mitchell, Douglas A. published an article.Name: 2-Chloro-4-nitrobenzoic acid The title of the article was HIV Protease Inhibitors Block Streptolysin S Production. And the article contained the following:

Streptolysin S (SLS) is a posttranslationally modified peptide cytolysin that is produced by the human pathogen Streptococcus pyogenes. SLS belongs to a large family of azole-containing natural products that are biosynthesized via an evolutionarily conserved pathway. SLS is an important virulence factor during S. pyogenes infections, but despite an extensive history of study, further investigations are needed to clarify several steps of its biosynthesis. To this end, chem. inhibitors of SLS biosynthesis would be valuable tools to interrogate the various maturation steps of both SLS and biosynthetically related natural products. Such chem. inhibitors could also potentially serve as antivirulence therapeutics, which in theory may alleviate the spread of antibiotic resistance. In this work, the authors demonstrate that FDA-approved HIV protease inhibitors, especially nelfinavir, block a key proteolytic processing step during SLS production This inhibition was demonstrated in live S. pyogenes cells and through in vitro protease inhibition assays. A panel of 57 nelfinavir analogs was synthesized, leading to a series of compounds with improved anti-SLS activity while illuminating structure-activity relationships. Nelfinavir was also found to inhibit the maturation of other azole-containing natural products, namely those involved in listeriolysin S, clostridiolysin S, and plantazolicin production The use of nelfinavir analogs as inhibitors of SLS production has allowed us to begin examining the proteolysis event in SLS maturation and will aid in further investigations of the biosynthesis of SLS and related natural products. The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).Name: 2-Chloro-4-nitrobenzoic acid

The Article related to hiv protease inhibitor streptolysin antibacterial streptococcus, Pharmacology: Structure-Activity and other aspects.Name: 2-Chloro-4-nitrobenzoic acid

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On March 14, 2019, Krall, Jacob; Bavo, Francesco; Falk-Petersen, Christina B.; Jensen, Claus H.; Nielsen, Julie O.; Tian, Yongsong; Anglani, Valeria; Kongstad, Kenneth T.; Piilgaard, Louise; Nielsen, Birgitte; Gloriam, David E.; Kehler, Jan; Jensen, Anders A.; Harpsoee, Kasper; Wellendorph, Petrine; Froelund, Bente published an article.Name: tert-Butyl trichloroacetimidate The title of the article was Discovery of 2-(Imidazo[1,2-b]pyridazin-2-yl)acetic acid as a new class of ligands selective for the γ-hydroxybutyric acid (GHB) high-affinity binding sites. And the article contained the following:

Gabazine, a γ-aminobutyric acid type A (GABAA) receptor antagonist, has previously been reported to inhibit the binding of [3H]NCS-382, a representative ligand of the high-affinity binding site for the neuroactive substance γ-hydroxybutyric acid (GHB). We herein report a study on the structural determinants of gabazine for binding to (i) the orthosteric binding site of the GABAA receptor and (ii) the high-affinity GHB binding site. Expanding the structural diversity of available ligands for the high-affinity GHB binding sites, this study identified 2-(imidazo[1,2-b]pyridazin-2-yl)acetic acid as a novel ligand-scaffold leading to analogs with relatively high affinity (Ki 0.19-2.19 μM) and >50 times selectivity for the [3H]NCS-382 over [3H]muscimol binding sites. These results highlight that gabazine interacts with the high-affinity GHB and orthosteric GABAA receptor binding sites differently and that distinct analogs can be generated to select between them. To facilitate further in vivo studies, a promising prodrug candidate for brain delivery was identified. The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Name: tert-Butyl trichloroacetimidate

The Article related to gabazine gamma hydroxybutyric acid high affinity binding site gabaa, Pharmacology: Structure-Activity and other aspects.Name: tert-Butyl trichloroacetimidate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On March 22, 2018, Gordon, Christopher P.; Dalton, Neal; Vandegraaff, Nicholas; Deadman, John; Rhodes, David I.; Coates, Jonathan A.; Pyne, Stephen G.; Griffith, Renate; Bremner, John B.; Keller, Paul A. published an article.Related Products of 99-60-5 The title of the article was A structure-based design approach to advance the allyltyrosine-based series of HIV integrase inhibitors. And the article contained the following:

As of mid-2017, only one structure of the human immunodeficiency virus (HIV) integrase core domain co-crystallized with an active site inhibitor was reported. In this structure (1QS4), integrase is complexed with a diketo-acid based strand-transfer inhibitor (INSTI). This structure has been a preferred platform for the structure-based design of INSTIs despite concerns relating to structural irregularities arising from crystallog. packing effects. A survey of the current pool of 297 reported integrase catalytic core structures indicated that the anatomy of the active site in the complex structure 1QS4 exhibits subtle variations relative to all other structures examined Consequently, the 1QS4 structure was employed for docking studies. From the docking of twenty-seven allyltyrosine analogs, a 3-point inhibitor binding motif required for activity was established and successfully utilized in the development of a tripeptide displaying an EC50 value of 10 ± 5 μM in HIV infected human T-cells. Addnl. docking of “inhouse” compound libraries unearthed a Me ester based nitrile derivative displaying an IC50 value of 0.5 μM in a combined 3′-processing and strand-transfer assay. The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).Related Products of 99-60-5

The Article related to structure preparation allyltyrosine derivative hiv integrase inhibitor, Pharmacology: Structure-Activity and other aspects.Related Products of 99-60-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Iwahashi, Maki; Naganawa, Atsushi; Kinoshita, Atsushi; Shimabukuro, Atsushi; Nishiyama, Toshihiko; Ogawa, Seiji; Matsunaga, Yoko; Tsukamoto, Kohki; Okada, Yutaka; Matsumoto, Ryoji; Nambu, Fumio; Oumi, Rie; Odagaki, Yoshihiko; Katagi, Jun; Yano, Koji; Tani, Kousuke; Nakai, Hisao; Toda, Masaaki published an article in 2011, the title of the article was Discovery of new orally active prostaglandin D2 receptor antagonists.Recommanded Product: 59833-69-1 And the article contains the following content:

To identify an orally available drug candidate, a series of 3-benzoylaminophenylacetic acids were synthesized and evaluated as prostaglandin D2 (PGD2) receptor antagonists. Some of the compounds tested were found to exhibit excellent inhibitory activity against cAMP accumulation in human platelet rich plasma (hPRP), which is one of the indexes of DP antagonism. The optimization process including improvement of the physicochem. properties such as solubility, which may result in an improved pharmacokinetic (PK) profile, is presented. Optimized compounds were studied for their pharmacokinetics and in vivo potential. A structure-activity relation study is also presented. Some of the test compounds were found to have in vivo efficacy towards the inhibition of PGD2-induced and OVA-induced vascular permeability in guinea pig conjunctiva. The experimental process involved the reaction of Methyl 2-(3-amino-4-chlorophenyl)acetate(cas: 59833-69-1).Recommanded Product: 59833-69-1

The Article related to prostaglandin d2 receptor antagonist preparation and structure activity, Pharmacology: Structure-Activity and other aspects.Recommanded Product: 59833-69-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On September 11, 2014, Beesu, Mallesh; Malladi, Subbalakshmi S.; Fox, Lauren M.; Jones, Cassandra D.; Dixit, Anshuman; David, Sunil A. published an article.Quality Control of 2-Chloro-4-methyl-1-nitrobenzene The title of the article was Human Toll-Like Receptor 8-Selective Agonistic Activities in 1-Alkyl-1H-benzimidazol-2-amines. And the article contained the following:

Toll-like receptor (TLR)-8 agonists strongly induce the production of T helper 1-polarizing cytokines and may therefore serve as promising candidate vaccine adjuvants, especially for the very young and the elderly. Earlier structure-based ligand design led to the identification of 3-pentyl-quinoline-2-amine as a novel, human TLR8-specific agonist. Comprehensive structure-activity relationships in ring-contracted 1-alkyl-1H-benzimidazol-2-amines were undertaken, and the best-in-class compound, 4-methyl-1-pentyl-1H-benzo[d]imidazol-2-amine, was found to be a pure TLR8 agonist, evoking strong proinflammatory cytokine and Type II interferon responses in human PBMCs, with no attendant CD69 upregulation in natural lymphocytic subsets. The 1-alkyl-1H-benzimidazol-2-amines represent a novel, alternate chemotype with pure TLR8-agonistic activities and will likely prove useful not only in understanding TLR8 signaling but also perhaps as a candidate vaccine adjuvant. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Quality Control of 2-Chloro-4-methyl-1-nitrobenzene

The Article related to alkyl benzimidazol amine derivative preparation toll receptor 8 adjuvant, Pharmacology: Structure-Activity and other aspects.Quality Control of 2-Chloro-4-methyl-1-nitrobenzene

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On April 8, 2021, Zhang, Han; Yu, Peilin; Lin, Hongwei; Jin, Zefang; Zhao, Siqi; Zhang, Yi; Xu, Qingxia; Jin, Hongwei; Liu, Zhenming; Yang, Wei; Zhang, Liangren published an article.Formula: C7H6ClNO2 The title of the article was The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo. And the article contained the following:

The transient receptor potential melastatin 2 (TRPM2) channel is associated with ischemia/reperfusion injury, inflammation, cancer, and neurodegenerative diseases. However, the limit of specific inhibitors impedes the development of TRPM2-targeted therapeutic agents. To discover more potent and selective TRPM2 inhibitors, 59 N-(p-amylcinnamoyl) anthranilic acid (ACA) derivatives were synthesized and evaluated using calcium imaging and electrophysiol. approaches. Systematic structure-activity relationship studies resulted in some potent compounds inhibiting the TRPM2 channel with sub-micromolar half-maximal inhibitory concentration values. Among them, the preferred compound A23 (I) exhibited TRPM2 selectivity over TRPM8 and TRPV1 channels as well as phospholipase A2 and showed neuroprotective activity in vitro. Following pharmacokinetic studies, I was further evaluated in a transient middle cerebral artery occlusion model in vivo, which significantly reduced cerebral infarction. These data indicate that A23 might serve as a useful tool for TRPM2-related research as well as a lead compound for the development of therapeutic agents for ischemic injury. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Formula: C7H6ClNO2

The Article related to amylcinnamoyl anthranilic acid synthesis sar neuroprotectant brain ischemia, Pharmacology: Structure-Activity and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Jeong, Yong-Chul; Anwar, Muhammad; Bikadi, Zsolt; Hazai, Eszter; Moloney, Mark G. published an article in 2013, the title of the article was Natural product inspired antibacterial tetramic acid libraries with dual enzyme inhibition.Synthetic Route of 35444-44-1 And the article contains the following content:

The application of natural product inspired synthesis has identified novel antibacterial tetramic acids which exhibit wide ranging antibacterial activity, and which provide potential lead structures for antibacterial drug discovery. Their phenotypic activity appears to correlate with action at two enzymes, UPPS and RNAP, which operate in independent metabolic pathways. SAR maps and identification of their relevant binding sites by mol. modeling has been achieved, and characterization of the most active compounds suggests that these systems offer potential for topical antibiotics but that for oral and injectable use further optimization is required. The experimental process involved the reaction of Methyl 6-chloro-6-oxohexanoate(cas: 35444-44-1).Synthetic Route of 35444-44-1

The Article related to natural product antibacterial tetramic acid upps rna polymerase haemophilus, Pharmacology: Structure-Activity and other aspects.Synthetic Route of 35444-44-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On March 15, 2013, Yu, Binxun; Huang, Zheng; Zhang, Min; Dillard, Darren R.; Ji, Haitao published an article.Safety of 2-Chloro-4-methyl-1-nitrobenzene The title of the article was Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor Protein-Protein Interactions by Bioisostere Replacement. And the article contained the following:

A new hot spot-based design strategy using bioisostere replacement is reported to rationally design nonpeptidic small-mol. inhibitors for protein-protein interactions. This method is applied to design new potent inhibitors for β-catenin/T-cell factor (Tcf) interactions. Three hot spot regions of Tcf for binding to β-catenin were quant. evaluated; the key binding elements around K435 and K508 of β-catenin were derived; a bioisostere library was used to generate new fragments that can match the proposed critical binding elements. The most potent inhibitor, with a mol. weight of 230, has a Kd of 0.531 μM for binding to β-catenin and a Ki of 3.14 μM to completely disrupt β-catenin/Tcf interactions. The binding mode of the designed inhibitors was validated by the site-directed mutagenesis and structure-activity relationship (SAR) studies. This study provides a new approach to design new small-mol. inhibitors that bind to β-catenin and effectively disrupt β-catenin/Tcf interactions specific for canonical Wnt signaling. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Safety of 2-Chloro-4-methyl-1-nitrobenzene

The Article related to beta catenin tcf protein interaction bioisostere structure activity preparation, Pharmacology: Structure-Activity and other aspects.Safety of 2-Chloro-4-methyl-1-nitrobenzene

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On February 28, 2011, Yamaoka, Nagahisa; Kodama, Hidehiko; Izuhara, Yuko; Miyata, Toshio; Meguro, Kanji published an article.COA of Formula: C7H11ClO3 The title of the article was Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitors. And the article contained the following:

Novel anthranilic acid derivatives having substituted N-acyl side chains were designed and synthesized for evaluation as plasminogen activator inhibitor-1 (PAI-1) inhibitors. Compounds with a 4-diphenylmethyl-1-piperazinyl moiety on the acyl side chains in general exhibited potent in vitro PAI-1 inhibitory activity and good pharmacokinetic profiles after oral administration in rats. Compound TM5275 was identified as a promising candidate for further pharmacol. evaluation. The experimental process involved the reaction of Methyl 6-chloro-6-oxohexanoate(cas: 35444-44-1).COA of Formula: C7H11ClO3

The Article related to acylanthranilate derivative preparation pai 1 inhibitor structure activity pharmacokinetics, Pharmacology: Structure-Activity and other aspects.COA of Formula: C7H11ClO3

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics